| LEADER 04334nam a22421 i 4500 |
| 001 13399111169 |
| 003 ULIBM |
| 006 m eo d |
| 007 cr cn |||m||| |
| 008 200328s2016 ob 000 0 eng |
| 020 ^a978080365779 |
| 020 ^a978080365705 |
| 020 ^a080366079 |
| 020 ^a080365705 |
| 041 0 ^aen |
| 050 00 ^aRM301.1 |
| 082 00 ^a615.102461 |
| 100 1 ^aVallerand, April Hazard |
| 245 10 ^aDavis's drug guide for nurses, 15th edition^h[electronic resource] /^cApril Hazard Vallerand, Cynthia A. Sanoski, Judith Hopfer Deglin |
| 250 ^a15th ed |
| 260 ^a[Place of publication not identified] :^bF.A. Davis Company,^c2016 |
| 300 ^ a1 online resource (1493 pages) |
| 504 ^ aIncludes bibliographical references and index. |
| 505 ^ aDavis's drug guide for nurses, 15th edition -- DEDICATION\ACKNOWLEDGMENTS -- CONSULTANTS -- F. A. DAVIS PHARMACOLOGIC PUBLICATIONS ADVISORY BOARD -- F.A. DAVIS CANADIAN ADVISORY BOARD -- CONTENTS -- HOW TO USE DAVIS’S DRUG GUIDE FOR NURSES -- EVIDENCE-BASED PRACTICE AND PHARMACOTHERAPEUTICS: IMPLICATIONS FOR NURSES -- PHARMACOGENOMICS -- MEDICATION ERRORS: IMPROVING PRACTICES AND PATIENT SAFETY -- DETECTING AND MANAGING ADVERSE DRUG REACTIONS -- OVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS) -- SPECIAL DOSING CONSIDERATIONS -- THE CYTOCHROME P450 SYSTEM: WHAT IS IT AND WHY SHOULD I CARE? -- EDUCATING PATIENTS ABOUT SAFE MEDICATION USE -- CLASSIFICATIONS\ANTI-ALZHEIMER'S AGENTS -- ANTIANEMICS -- ANTIANGINALS -- ANTIANXIETY AGENTS -- ANTIARRHYTHMICS -- ANTIASTHMATICS -- ANTICHOLINERGICS -- ANTICOAGULANTS -- ANTICONVULSANTS -- ANTIDEPRESSANTS -- ANTIDIABETICS -- ANTIDIARRHEALS -- ANTIEMETICS -- ANTIFUNGALS -- ANTIHISTAMINES -- ANTIHYPERTENSIVES -- ANTI-INFECTIVES -- ANTINEOPLASTICS -- ANTIPARKINSON AGENTS -- ANTIPLATELET AGENTS -- ANTIPSYCHOTICS -- ANTIPYRETICS -- ANTIRETROVIRALS -- ANTIRHEUMATICS -- ANTITUBERCULARS -- ANTIULCER AGENTS -- ANTIVIRALS -- BETA BLOCKERS -- BONE RESORPTION INHIBITORS -- BRONCHODILATORS -- CALCIUM CHANNEL BLOCKERS -- CENTRAL NERVOUS SYSTEM STIMULANTS -- CORTICOSTEROIDS -- DIURETICS -- HORMONES -- IMMUNOSUPPRESSANTS -- LAXATIVES -- LIPID-LOWERING AGENTS -- MINERALS/ELECTROLYTES/pH MODIFIERS -- NATURAL/HERBAL PRODUCTS -- NONOPIOID ANALGESICS -- NONSTEROIDAL ANTI-INFLAMMATORY AGENTS -- OPIOID ANALGESICS -- SEDATIVE/HYPNOTICS -- SKELETAL MUSCLE RELAXANTS -- THROMBOLYTICS -- VACCINES/IMMUNIZING AGENTS -- VITAMINS -- WEIGHT CONTROL AGENTS -- DRUG MONOGRAPHS IN ALPHABETICAL ORDER BY GENERIC NAME -- DRUGS APPROVED IN CANADA -- NATURAL/HERBAL PRODUCTS -- MEDICATION SAFETY TOOLS -- APPENDICES -- APPENDIX A: RECENT DRUG APPROVALS -- APPENDIX B: COMBINATION DRUGS -- APPENDIX C: OPHTHALMIC MEDICATIONS -- APPENDIX D: MEDICATION ADMINISTRATION TECHNIQUES -- APPENDIX E: FORMULAS HELPFUL FOR CALCULATING DOSES -- APPENDIX F: NORMAL VALUES OF COMMON LABORATORY TESTS -- APPENDIX G: PREGNANCY CATEGORIES -- APPENDIX H: CONTROLLED SUBSTANCES SCHEDULES -- APPENDIX I: EQUIANALGESIC DOSING GUIDELINES -- APPENDIX J: FOOD SOURCES FOR SPECIFIC NUTRIENTS -- APPENDIX K: INSULINS AND INSULIN THERAPY -- APPENDIX L: CANADIAN AND U.S. PHARMACEUTICAL PRACTICES -- APPENDIX M: ROUTINE PEDIATRIC AND ADULT IMMUNIZATIONS -- APPENDIX N: ADMINISTERING MEDICATIONS TO CHILDREN -- APPENDIX O: PEDIATRIC DOSAGE CALCULATIONS -- APPENDIX P: PEDIATRIC FLUID AND ELECTROLYTE REQUIREMENTS -- BIBLIOGRAPHY -- COMPREHENSIVE INDEX. |
| 506 aA ccess restricted to authorized users and institutions. 3 |
| 520 aD avis’s Drug Guide for Nurses®, Fifteenth Edition delivers all of the information you need to administer medications safely across the lifespan—well-organized monographs for hundreds of generic and thousands of trade-name drugs. ^aMo |
| 538 o f access: World Wide Web. 0^aDr |
| 650 ic al pharmacology 4^aEl |
| 650 in g 0^aCl |
| 650 s 0^aNu |
| 655 tr onic books. 1 ^aSa |
| 700 in , Judith Hopfer,^eauthor 40^uht |
| 700 sk i, Cynthia A.,^eauthor 1 ^aDe |
| 856 s: //portal.igpublish.com/iglibrary/search/FADAVISB0000563.html |
Union Library Management V6
แสดงรายละเอียดบรรณานุกรม
QR code
ปิดหน้าต่าง
E-books : เกี่ยวกับ Collections
Copyright 2024. All Rights Reserved.